Corporate
Mar. 26, 2011
Abbott Antitrust Suit Goes to Jury
GlaxoSmithKline is asking a federal jury to award it $571.6 million in a trial in which it claims competitor Abbott Laboratories violated antitrust laws by raising the price of an HIV drug.
Daily Journal Staff Writer
OAKLAND - When Abbott Laboratories' trial began last month, it was facing off against four sets of plaintiffs who claimed the pharmaceutical company's increase of the price of an HIV drug by 400 percent violated antitrust laws.
But by the time the trial drew to a close Thursday, most of the plaintiffs, including a class of drug wholesalers - along with Walgreens Co., Rite Aid Corp. and CVS ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In